The Oct-3/4 transcription factor is expressed in the earliest stages of emb
ryogenesis, and is thus likely to play an important role in regulation of i
nitial decisions in development For the first time, We have shown that SF1
and Oct-3/4 are co-expressed in embryonal carcinoma (EC) P19 cells, and the
ir expression is down-regulated with very similar kinetics following retino
ic acid (RA) induced differentiation of these cells, suggesting a functiona
l relationship between the two. Previously, Re have shown that the Oct-3/4
promoter harbors an RA-responsive element, RAREoct, which functions in EC c
ells as a binding site for positive regulators of transcription, such as RA
R and RXR. In this study we have identified in the Oct-3/4 promoter two nov
el SF1-binding sites: SF1(a) and SF1(b). The proximal site, SF1(a), is loca
ted within the RAREoct, and the distal site, SF1(b), is located between nuc
leotide -193 and -209 of the Oct-3/4 promoter. Both sites contribute to act
ivation of Oct-3/4 promoter in EC cells, with SF1(a) playing a more crucial
role. SF1, and its isoforms ELP2 and ELP3 bind to both SF1 sites and activ
ate the Oct-3/4 promoter. This activation depends on the presence of SF1 DN
A-binding domain. Thus, Oct-3/4 is the first EC-specific gene reported that
is regulated by SF1. Interestingly, SF1 and RAR form a novel complex on th
e RAREoct sequence that synergistically activate the Oct-3/4 promoter. Both
RARE and SF1 cis regulatory elements, as well as the SF1 DNA-binding domai
n, are needed for this synergism, SF1 and Oct-3/4 transcription factors pla
y a role in the same developmental regulatory cascade.